VIA
RVMD icon

Virtus Investment Advisers’s Revolution Medicines RVMD Stock Holding History

Virtus Investment Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Sell
2,127
-1,327
-38% -$194K 0.09% 281
2026
Q1 		$336K Buy
3,454
+83
+2% +$8.38K 0.09% 264
2025
Q4 		$269K Buy
3,371
+603
+22% +$39.5K 0.07% 298
2025
Q3 		$129K Buy
2,768
+481
+21% +$18.8K 0.04% 397
2025
Q2 		$84.1K Sell
2,287
-1,365
-37% -$52.4K 0.03% 405
2025
Q1 		$129K Buy
+3,652
New +$148K 0.04% 377

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Virtus Investment Advisers's RVMD Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Revolution Medicines (RVMD) stake by 38% in Q2 2026, selling an estimated $194K and leaving 2,127 shares worth $398K. The position accounts for 0.09% of the portfolio, ranked #281.

Virtus Investment Advisers first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Virtus Investment Advisers held 2,127 shares of Revolution Medicines worth $398K as of Q2 2026.
  • Virtus Investment Advisers sold 1,327 Revolution Medicines shares in Q2 2026, an estimated $194K.
  • Revolution Medicines made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #281 holding.
  • Virtus Investment Advisers first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.